Back to results
US 7,723,515 B1Granted
Methylene blue—curcumin analog for the treatment of alzheimer's disease
AssigneeCodman & Shurtleff, Inc.
InventorThomas M. DiMauro
Life of this patent
Estimating the term…
Abstract
A methylene blue—curcumin hybrid useful in treating Alzheimer's Disease.
Claims1
2,6-bis(4′, 4″ dihydroxyphenyl), 3,7-bis(dimethylamino)-phenazathionium chloride.
Dependencies are inferred from the claim text.